Fibromyalgia is a chronic condition characterised by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties ("brain fog"). The underlying mechanism involves altered pain processing and neurotransmitter dysregulation. Treatment aims to reduce symptoms, improve function, and enhance quality of life.
Pharmacotherapy is multimodal: pregabalin or gabapentin (anticonvulsants) reduce pain and are first-line FDA-approved agents; amitriptyline (tricyclic antidepressant) improves sleep and pain; duloxetine (SNRI antidepressant) targets both pain and mood. NSAIDs are less effective than in inflammatory arthritis but may help. Aerobic exercise—walking, water exercise, cycling—is essential and evidence-backed; structured programmes over 12 weeks improve pain and fatigue significantly. Sleep hygiene and cognitive-behavioural therapy (CBT) address sleep disturbance and psychological factors. Mindfulness-based stress reduction (MBSR) and acceptance-commitment therapy (ACT) reduce pain perception and improve coping. Heat therapy, gentle stretching, and relaxation techniques provide symptomatic relief.
Acupuncture shows modest evidence for fibromyalgia pain relief and is widely used; effects vary. Herbal supplements (valerian, passionflower for sleep; turmeric, ginger for pain) are popular with limited evidence. Magnesium supplementation may help some, particularly if deficient. Coenzyme Q10, vitamin D, and B-complex vitamins are used though evidence is mixed. Manual therapy (massage, myofascial release) and osteopathy provide temporary comfort. Hyperbaric oxygen therapy and low-dose naltrexone (LDN, off-label) have emerging but limited evidence.
Regenerative approaches for fibromyalgia remain largely unexplored due to the condition's non-structural, neurobiological nature. However, research is beginning to investigate whether stem cells and exosomes can reduce central inflammation or modulate immune dysfunction. Preliminary data suggests mesenchymal stem cells may have anti-inflammatory effects potentially beneficial in fibromyalgia. These approaches are highly experimental and not yet available clinically. Interest in regenerative strategies stems from the belief that immune and neuroinflammatory pathways underlie symptoms. Follow emerging fibromyalgia research directions and research participation for updates.
| Option | Type | Evidence | Indicative cost | Invasiveness | Recovery |
|---|---|---|---|---|---|
| Pregabalin or gabapentin | Standard | Strong | €20–100/month | Low | Ongoing; 1–4 weeks to benefit |
| Amitriptyline or duloxetine | Standard | Strong | €10–50/month | Low | Ongoing; 2–6 weeks benefit |
| Aerobic exercise programme | Standard | Strong | €0–100/month | Low | Ongoing; 8–12 weeks improvement |
| Cognitive-behavioural therapy (CBT) | Standard | Strong | €80–150 per session | Low | Ongoing; 8–16 sessions typical |
| Sleep hygiene & optimisation | Standard | Moderate | €0–100 | Low | Ongoing; 2–4 weeks benefit |
| Acupuncture | Alternative | Moderate | €50–80 per session | Low | None; multiple sessions needed |
| Mindfulness-based stress reduction (MBSR) | Alternative | Moderate | €200–400 per 8-week course | Low | None; ongoing practice |
| Stem-cell immunomodulation (exploratory) | Regenerative | Investigational | €5,000–15,000 | Low–Medium | Few days; very early-stage research |
Exercise counters the pain-deconditioning cycle; inactivity worsens fatigue and pain perception. Gradual, sustained aerobic activity (even gentle: 20–30 minutes, 3–5×/week) improves pain processing, sleep, and mood. Start low and progress slowly; a physiotherapist can tailor a safe programme.
Antidepressants like amitriptyline and duloxetine modulate neurotransmitters (serotonin, noradrenaline) involved in pain processing and sleep, independent of mood effects. They are effective for neuropathic and fibromyalgia pain at lower doses (25–75 mg) than those used for depression.
Fibromyalgia is chronic but variable. Symptoms fluctuate; some people experience periods of improvement or remission, especially with sustained treatment and lifestyle changes. While not curable, combination therapy (medication, exercise, psychological support) significantly improves quality of life for most patients.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Educational overview of treatment options; not medical advice. Standard treatments reflect mainstream guidance; regenerative/stem-cell uses are largely investigational. Reviewed by the StemCellAtlas editorial team.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită